Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene

Andrew C. Karaplis, Arne Luz, Julia Glowacki, Roderick T. Bronson, Victor L.J. Tybulewicz, Henry M. Kronenberg, Richard C. Mulligan

Research output: Contribution to journalArticlepeer-review

1032 Scopus citations

Abstract

The parathyroid hormone-related peptide (PTHrP) gene was disrupted in murine embryonic stem cells by homologous recombination, and the null allele was introduced into the mouse germ line. Mice homozygous for the PTHrP null mutation died postnatally, probably from asphyxia, and exhibited widespread abnormalities of endochondral bone development. Histological examination revealed a diminution of chondrocyte proliferation, associated with premature maturation of chondrocytes and accelerated bone formation. Analysis of earlier developmental stages revealed that disturbance in cartilage growth preceded abnormal endochondral bone formation. There were no morphological abnormalities apparent in other tissues. These results provide direct evidence implicating PTHrP in normal skeletal development and serve to emphasize its potential involvement in human osteochondrodysplasias.

Original languageEnglish
Pages (from-to)277-289
Number of pages13
JournalGenes and Development
Volume8
Issue number3
DOIs
StatePublished - 1994
Externally publishedYes

Keywords

  • PTHrP
  • chondrocyte differentiation
  • chondrodysplasia
  • fetal skeletal development
  • gene targeting

Fingerprint

Dive into the research topics of 'Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene'. Together they form a unique fingerprint.

Cite this